Dozens of different animal models of PD have revealed that PPARγ activation reduces levels of OS and inflammation, improves mitochondrial function, reduces glial activation, slows the rate of nigral dopaminergic neuron loss, and increases striatal dopamine levels (Fig. 5) [55, 56]. Here, PPARG is linked to Parkinson disease.